Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

The paper's citation list
No.The paper's citation list
1Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion. 2021;10:582 doi: 10.3390/jcm10040582
2Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. 2021;13:4808 doi: 10.3390/cancers13194808
3Estrogen receptor expression is modulated in human and mouse prostate epithelial cells during cancer progression. 2022;184:109036 doi: 10.1016/j.steroids.2022.109036
4Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors. 2021;18:1455 doi: 10.1021/acs.molpharmaceut.1c00018
5Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. 2020;22: doi: 10.1186/s13058-020-01325-3
6The role of interactomic interactions in tamoxifen-resistant breast cancer: new approaches to searching for the mechanisms of pathogenesis. 2020;9:80 doi: 10.17116/onkolog2020906180
7An Interdependence between Estrogen Receptor 1 Gene Polymorphisms and Susceptibility to Breast Cancer. 2021;1: doi: 10.5812/tms.117221
8Widespread Exaptation of L1 Transposons for Transcription Factor Binding in Breast Cancer. 2021;22:5625 doi: 10.3390/ijms22115625
9New fluorobenzamidine exerts antitumor activity against breast cancer in mice via pro-apoptotic activity. 2022;13: doi: 10.1007/s12672-022-00554-6
10Understanding the interaction of estrogenic ligands with estrogen receptors: a survey of the functional and binding kinetic studies. 2020;38:142 doi: 10.1080/26896583.2020.1761204
11Opportunities for Antigen Discovery in Metastatic Breast Cancer. 2020;11: doi: 10.3389/fimmu.2020.570049
12Identification and targeting of selective vulnerability rendered by tamoxifen resistance. 2020;22: doi: 10.1186/s13058-020-01315-5
13Management of hormone receptor–positive, human epidermal growth factor 2–negative metastatic breast cancer. 2021;190:189 doi: 10.1007/s10549-021-06383-5
14Targeting aberrant replication and DNA repair events for treating breast cancers. 2022;5: doi: 10.1038/s42003-022-03413-w
15microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer. 2020;10: doi: 10.3389/fonc.2020.00753
16Integrated transcription factor profiling with transcriptome analysis identifies L1PA2 transposons as global regulatory modulators in a breast cancer model. 2021;11: doi: 10.1038/s41598-021-86395-9
17Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis. 2021;10:2966 doi: 10.3390/cells10112966
18Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer. 2020;21:8807 doi: 10.3390/ijms21228807
19Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer. 2020;21:4068 doi: 10.3390/ijms21114068
20Role of the Mediator Complex and MicroRNAs in Breast Cancer Etiology. 2022;13:234 doi: 10.3390/genes13020234
21Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. 2021;11: doi: 10.3389/fonc.2021.645698
22Genomic Assays in Node Positive Breast Cancer Patients: A Review. 2021;10: doi: 10.3389/fonc.2020.609100
23Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations. 2020;10:698 doi: 10.3390/biom10050698
24Circulating Tumor Cells in Metastatic Breast Cancer: From Genome Instability to Metastasis. 2020;7: doi: 10.3389/fmolb.2020.00134
25Identification of Key lncRNA–mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data. 2021;12: doi: 10.3389/fgene.2021.709514
26Detection of ESR1 Mutations Based on Liquid Biopsy in Estrogen Receptor-Positive Metastatic Breast Cancer: Clinical Impacts and Prospects. 2020;10: doi: 10.3389/fonc.2020.587671
27Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer. 2021;13:6314 doi: 10.3390/cancers13246314
28Oxidative stress and gender disparity in cancer. 2022;56:90 doi: 10.1080/10715762.2022.2038789
29Identification of molecular biomarkers and pathways of NSCLC: insights from a systems biomedicine perspective. 2021;19: doi: 10.1186/s43141-021-00134-1
30FOXO transcription factor family in cancer and metastasis. 2020;39:681 doi: 10.1007/s10555-020-09883-w
31ESR1 fusions and therapeutic resistance in metastatic breast cancer. 2023;12: doi: 10.3389/fonc.2022.1037531
32Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis. 2021;12: doi: 10.1007/s12672-021-00432-7
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties